• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与尿白蛋白肌酐比值相比,评估尿足突细胞黏蛋白作为肥胖相关肾病患儿及青少年肾小球损伤标志物的情况。

Assessment of urinary podocalyxin as a marker of glomerular injury in obesity-related kidney disease in children and adolescents with obesity compared to urinary albumin creatinine ratio.

作者信息

Musa Noha, Ramzy Tarek, Hamdy Ahmed, Arafa Noha, Hassan Mona

机构信息

Diabetes, Endocrine and Metabolism Pediatric Unit (DEMPU), Cairo University, Cairo, Egypt.

Lecturer of Chemical pathology, Cairo University, Cairo, Egypt.

出版信息

Clin Obes. 2021 Aug;11(4):e12452. doi: 10.1111/cob.12452. Epub 2021 Apr 2.

DOI:10.1111/cob.12452
PMID:33797164
Abstract

Obesity increases the risk of chronic kidney disease in children. Our aim was to assess urinary podocalyxin (PCX) in children and adolescents with obesity as a potential marker of obesity-related kidney disease (ORKD). The current case-control study included 128 children with obesity compared to 60 non-obese age and sex matched controls. Study population were subjected to full history taking as well as thorough physical examination. Urine samples for albumin creatinine ratio (uACR) and PCX were collected from the study population as well as blood samples for assessment of serum creatinine and fasting lipid profile. A statistically significant difference was found between cases and controls regarding urinary PCX (P < .001) and uACR (P = .021). A statistically significant positive correlation was found between uACR and weight SD score (SDS), body mass index SDS, waist circumference, estimated glomerular filtration rate, triglycerides (TG) as well as urinary PCX, whilst urinary PCX correlated significantly with obesity duration and uACR. Cases with microalbuminuria had a statistically significant higher waist circumference, waist-hip ratio, fat percentage, TG and urinary PCX compared to those with normal uACR (P = .042, .034, .05, .018 and .036 respectively). Urinary PCX showed 83.3% sensitivity and 74% specificity in detection of albuminuria. Urinary PCX was increased significantly in children with obesity making it a potential sensitive marker of ORKD in children.

摘要

肥胖会增加儿童患慢性肾病的风险。我们的目的是评估肥胖儿童和青少年的尿足突细胞蛋白(PCX),将其作为肥胖相关肾病(ORKD)的潜在标志物。当前的病例对照研究纳入了128名肥胖儿童,并与60名年龄和性别匹配的非肥胖对照进行比较。研究人群接受了详细的病史采集以及全面的体格检查。从研究人群中采集了尿白蛋白肌酐比值(uACR)和PCX的尿液样本,以及用于评估血清肌酐和空腹血脂谱的血液样本。在病例组和对照组之间,尿PCX(P < 0.001)和uACR(P = 0.021)存在统计学显著差异。uACR与体重标准差评分(SDS)、体重指数SDS、腰围、估计肾小球滤过率、甘油三酯(TG)以及尿PCX之间存在统计学显著的正相关,而尿PCX与肥胖持续时间和uACR显著相关。与uACR正常的患者相比,微量白蛋白尿患者的腰围、腰臀比、脂肪百分比、TG和尿PCX在统计学上显著更高(分别为P = 0.042、0.034、0.05、0.018和0.036)。尿PCX在检测蛋白尿方面显示出83.3%的敏感性和74%的特异性。肥胖儿童的尿PCX显著升高,使其成为儿童ORKD的潜在敏感标志物。

相似文献

1
Assessment of urinary podocalyxin as a marker of glomerular injury in obesity-related kidney disease in children and adolescents with obesity compared to urinary albumin creatinine ratio.与尿白蛋白肌酐比值相比,评估尿足突细胞黏蛋白作为肥胖相关肾病患儿及青少年肾小球损伤标志物的情况。
Clin Obes. 2021 Aug;11(4):e12452. doi: 10.1111/cob.12452. Epub 2021 Apr 2.
2
Urinary podocalyxin, the novel biomarker for detecting early renal change in obesity.尿足细胞表面蛋白,用于检测肥胖早期肾脏变化的新型生物标志物。
J Nephrol. 2016 Feb;29(1):37-44. doi: 10.1007/s40620-015-0199-8. Epub 2015 Apr 24.
3
Assessment of urinary podocalyxin as an alternative marker for urinary albumin creatinine ratio in early stage of diabetic kidney disease in older patients.评估尿足细胞标记蛋白作为老年患者糖尿病肾病早期尿白蛋白肌酐比值的替代标志物。
Nefrologia (Engl Ed). 2022 Nov-Dec;42(6):664-670. doi: 10.1016/j.nefroe.2022.11.007. Epub 2022 Nov 17.
4
Urinary sediment podocalyxin in children with glomerular diseases.肾小球疾病患儿尿沉渣中的足细胞表面蛋白
Nephron Clin Pract. 2003;95(3):c91-9. doi: 10.1159/000074322.
5
Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.尿足细胞 podocalyxin 阳性物在糖尿病肾病早期出现,与临床诊断的糖尿病肾病相关。
J Diabetes Complications. 2014 Jan-Feb;28(1):96-100. doi: 10.1016/j.jdiacomp.2013.08.006. Epub 2013 Sep 24.
6
Podocalyxin expression in renal tissues and correlation with the number of urinary podocytes in children with Henoch-Schonlein purpura nephritis.紫癜性肾炎患儿肾组织中足细胞标记蛋白的表达及其与尿足细胞数量的相关性
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 Feb;37(2):161-7. doi: 10.3969/j.issn.1672-7347.2012.02.009.
7
Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.成年 IgA 肾病患者尿足细胞 podocalyxin 水平、尿足细胞数与组织学损伤的关系。
Clin J Am Soc Nephrol. 2012 Sep;7(9):1385-93. doi: 10.2215/CJN.08110811. Epub 2012 Jun 14.
8
ELISA analysis of urinary nephrin and podocalyxin standardized by aquaporin-2 in adult patients with nephrotic syndrome.水通道蛋白-2标准化的成人肾病综合征患者尿中nephrin和足突膜蛋白的ELISA分析
J Nephrol. 2014 Aug;27(4):411-7. doi: 10.1007/s40620-014-0066-z. Epub 2014 Apr 16.
9
Prevalence and factors related to urinary albumin excretion in obese youths.肥胖青少年尿白蛋白排泄的患病率及相关因素
J Hypertens. 2013 Nov;31(11):2230-6; discussion 2236. doi: 10.1097/HJH.0b013e328364bcbf.
10
Alleviation of podocyte injury: the possible pathway implicated in anti-inflammation of alpha-lipoic acid in type 2 diabetics.减轻足细胞损伤:α-硫辛酸在2型糖尿病抗炎作用中的可能途径
Aging Clin Exp Res. 2014 Oct;26(5):483-9. doi: 10.1007/s40520-014-0207-1. Epub 2014 Mar 22.

引用本文的文献

1
Obesity‑related kidney disease: a review on ultrasound applications.肥胖相关性肾病:超声应用综述
Ital J Pediatr. 2025 Aug 12;51(1):251. doi: 10.1186/s13052-025-02090-9.
2
Obesity-related glomerulopathy: How it happens and future perspectives.肥胖相关性肾小球病:发病机制及未来展望
Diabet Med. 2025 Jun;42(6):e70042. doi: 10.1111/dme.70042. Epub 2025 Apr 14.
3
Childhood Obesity: Insight into Kidney Involvement.儿童肥胖症:对肾脏受累的深入了解。
Int J Mol Sci. 2023 Dec 12;24(24):17400. doi: 10.3390/ijms242417400.
4
Emerging Biomarkers for Early Detection of Chronic Kidney Disease.用于慢性肾脏病早期检测的新兴生物标志物
J Pers Med. 2022 Mar 31;12(4):548. doi: 10.3390/jpm12040548.